Clinical Trial Update: Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cyclophosphamide with or without rituximab followed by peripheral stem cell transplantation in patients with recurrent non-Hodgkin ly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Rituximab (rituximab)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED